Asparaginyl endopeptidase (AEP)/legumain, an asparagine-specific cysteine proteinase in animals, is an ortholog of plant vacuolar processing enzyme which processes the exposed asparagine residues of various vacuolar proteins. In search for its physiological role in mammals, here we generated and characterized AEP-deficient mice. Although their bodyweights were significantly reduced, they were normally born and fertile. In the wildtype kidney, where the expression of AEP was exceedingly high among various organs, the localization of AEP was mainly found in the lamp-2-positive late endosomes in the apical region of the proximal tubule cells. In these cells of AEP-deficient mice, the lamp-2-positive membrane structures were found to be greatly enlarged. These aberrant lysosomes, merged with the late endosomes, accumulated electron-dense and membranous materials. Furthermore, the processing of the lysosomal proteases, cathepsins B, H, and L, from the single-chain forms into the two-chain forms was completely defected in the deficient mice. Thus, the AEP-deficiency caused the accumulation of macromolecules in the lysosomes, highlighting a pivotal role of AEP in the endosomal/lysosomal degradation system. by guest on October 5, 2017
Introduction
Lysosomes contain a variety of acid hydrolytic enzymes including proteases, glycosidases, and lipases and thereby provide the major site for degradation of macromolecules within a cell (1, 2) . Two processes are responsible for the uptake of molecules in the lysosomes, autophagy and endocytosis. Cytoplasmic components, including long-lived proteins and organelles, are delivered to the lysosomes via autophagy. Extracellular or cell surface molecules are transported to the lysosomes via endocytic pathways by passing through two sequential intermediates, early and late endosomes. Obstruction of the degradation process in human leads to severe diseases generally called lysosomal storage disease (3, 4) .
Most of these diseases are autosomal recessive inherited disorders caused by a deficiency of a lysosomal enzyme. Thus, lysosomal degradation contributes to maintain homeostasis not only intracellularly, but also throughout the body.
Asparaginyl endopeptidase (AEP, EC 3.4.22.34), also called legumain, belongs to the cysteine peptidase family C13 (5) . This family was originally identified in higher plants as vacuolar processing enzyme (VPE), which is the enzyme responsible for the processing and maturation of seed storage proteins in the vacuole (6) . AEP shows the strict substrate specificity toward the carbonyl side of exposed asparagine residues on the surface of substrate molecules (7, 8) . AEP is synthesized as an inactive preproprotein and auto-catalytically processed into the active mature forms. C-terminal and N-terminal propeptides of AEP are sequentially removed during its delivery to the acidic compartment (9, 10) . C-terminal propeptide acts as an auto-inhibitory domain that masks the catalytic site, therefore the removal of C-terminal propeptide is sufficient for the activation of AEP (11, 12) .
Although AEP is postulated to have a regulatory role in the biosynthesis of lysosomal enzymes, only a few studies have examined the physiological function of AEP in mammals. The microbial antigen tetanus toxin C fragment is processed into peptides by AEP in the endosomal/lysosomal system of B cells. The generated peptides are then loaded on class II major histocompatibility complex (MHC II) molecules for antigen by guest on http://www.jbc.org/
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Characterization of AEP-deficient mice 4 presentation (13) . Myelin basic protein (MBP) is a potential human autoantigen for MHC II that is implicated in the pathogenesis of multiple sclerosis. A dominant epitope of MBP contains a processing site for AEP. The destruction processing of this epitope by AEP limits its presentation in thymus (14) (15) (16) . In addition to these functions of AEP, the Cterminal propeptide of AEP was identified as an inhibitor of osteoclast differentiation (17) .
The C-terminal propeptide was found to act as an inhibitor of AEP (11, 12) , and so there is a possibility that AEP is involved in the process of osteoclast differentiation.
In this study, we examined the physiological function of AEP in vivo by generating and characterizing the AEP-deficient mice. AEP was abundantly expressed in kidney and localized in the late endosomes of the proximal tubule cells. Disruption of the AEP gene led to the enlargement of lysosomes in these cells in an age-dependent manner, which suggests that materials to be degraded are being accumulated within the lysosomal compartments. Activities of lysosomal proteases, cathepsin B and dipeptidyl peptidase (DPP) II, increased, while the cathepsin H activity slightly decreased. These results suggest that AEP has an important role in the endosomal/lysosomal degradation of kidney proximal tubule cells. Characterization of AEP-deficient mice 6 neomycin-resistant clones revealed the desired homologous recombination. These clones were also subjected to a Southern blot analysis using a neo probe to be tested for a single integration. To obtain a deleted allele, AxCANCre, an adenovirus vector expressing Cre recombinase (22) , was used to infect two independent ES clones. Thirty-five clones out of the selected 46 clones had the desired deletion. The EcoRI fragment of the genomic DNA was subjected to Southern blot analyses using an external 3'-probe to confirm the deletion (Fig. 1B, lane 3) . Chimeric mice were generated by the sandwich aggregation method (23) using two floxed ES cell clones and two deleted ES cell clones. Germ line transmission was confirmed with every clone. Mice heterozygous for the mutation were obtained by crossbreeding of the chimeras with C57BL/6J (B6) females. The resulting heterozygotes were then inter-crossed to obtain homozygous and wild-type littermates, or further backcrossed with B6 mice. Genotypes were determined by PCR of tail DNA (Fig. 1C) . Antibodies -Anti-mouse AEP antibodies were prepared by immunizing rabbits with a bacterially expressed 6 x His tagged fusion protein of AEP (from Cys-52 to His-164).
We used a monoclonal antibody for lamp-2 (rat clone GL2A7) from the Developmental The sections were incubated with the primary antibodies followed by fluorescence-labeled secondary antibodies and inspected with a laser-scanning confocal imaging system (LSM510, Carl Zeiss).
Electron Microscopy -Mice were fixed as described above except that 2.5% glutaraldehyde was used instead of 4% paraformaldehyde. The removed kidneys were further fixed for 2 h in the same fixative, and subjected to standard electron microscopic techniques as described previously (25) . For immunoelectron microscopy, the cryosections, prepared as described above, were reacted with anti-AEP antibodies followed by colloidal gold-conjugated secondary antibodies. The gold labeling was intensified with a silver enhancement kit (Nano Probes) as previously described (26) . The cryosections were then dehydrated, embedded in LR-white, and processed further by guest on http://www.jbc.org/
Characterization of AEP-deficient mice 9 according to standard electron microscopic technique (25) . Ultra-thin sections were observed under a Hitachi H700 electron microscopy (Hitachi, Japan).
Results

AEP-Deficient
Mice -AEP mRNA expression was by far the highest in kidney (Fig. 1D) as reported previously (5, 27, 28) . The expression levels in other organs such as eye, liver and lung, were less than an eighth of that in kidney. To demonstrate an in vivo physiological role of AEP, we generated AEP-deficient (AEP and L were detected as both the single-chain and two-chain forms (Fig. 3A) . In contrast, only the single-chain form of each cathepsin was detected in the AEP -/-mice (Fig. 3A) .
This result clearly demonstrates that AEP is responsible for processing from the singlechain form into the two-chain form for cathepsins B, H, and L. In addition, it is noteworthy that the amount of cathepsins, especially for cathepsin L, increased in the AEP -/-mice (see discussion below).
Next we determined how the defects in the processing into the two-chain forms month-old-mice were fixed by perfusion and subjected to the analyses. Essentially the same results were obtained from each of 1-, 3-and 12-month-old-mice. AEP was found in a quite restricted region in the cortex (Fig. 4A, right) , but not in the medulla including the collecting tubule or the urinary tubule cells (data not shown). In the cortex, prominent AEP signals were detected at the proximal tubules and weak signals were observed at the distal tubules. In contrast, considerable signals were not detected at glomeruli. Preimmune serum did not make any signals (data not shown).
In the kidney proximal tubule cells, AEP was localized to the punctate structures in the apical region within the cell. To elucidate what the structures were, we performed double-labeling immunofluorescent microscopy with antibodies against cathepsin D, a lysosomal protease (Fig. 4B) . The AEP-containing structures were mostly found on the apical side of the cells (Fig. 4B, left) , while cathepsin D-positive lysosomes were distributed in the middle region of the cells (Fig. 4B, middle) . AEP was scarcely colocalized with cathepsin D (Fig. 4B, right) . These results suggest that AEP is localized in a subcellular compartment other than lysosomes.
We next compared the localization of AEP with that of lamp-2, a marker for the late endosomes and lysosomes (30). Most structures stained with anti-AEP antibodies were stained with anti-lamp-2 monoclonal antibody (Fig. 4C, right) . This result suggested that AEP was localized in the late endosomes of the kidney proximal tubule cells. We excluded the possibility that AEP was localized to the early endosomes, because almost all AEP signals overlapped with those of lamp-2.
To demonstrate the subcellular localization in greater detail, immunoelectron microscopy was performed with ultra-thin sections prepared from a kidney of a 4-weekold mouse. In the proximal tubule cells, AEP was localized in electron-lucent multivesicular-body-like structures, but not in the electron-dense uniform structures ( (Fig. 3A) . This result was consistent with the finding that the processing sites of cathepsin B and cathepsin H are asparagine residue (32), which are preferential sites for AEP activity. The processing of cathepsin L occurs at a site containing an aspartic acid (33, 34) . A plant AEP ortholog, VPE, has been shown to recognize aspartic acid residues as well as asparagine residues (35) . We observed that AEP also cleaves a peptide bond at the carbonyl side of aspartic acid, although the activity toward aspartic acid is quite lower than that toward asparagine 2 (10). The AEP -/-mice lacked the activity to cleave the asparaginyl bond (Fig. 3B) , showing that AEP is the major protease specific to asparagine under acidic conditions. Thus, AEP must be directly involved in the producing the two-chain forms of cathepsins B, H, and L.
Here we found that the lysosomes of the AEP -/-mice became enlarged in the proximal tubule cells (Fig. 5) . We did not find the enlarged lysosomes in other regions of kidney. This is in good agreement with the distribution of AEP in kidney (Fig. 4A) . The proximal tubule cells, which abundantly express AEP, have excessive apical endocytic compartments that are critical for the reabsorption and degradation of macromolecule (31) .
These cells are the most active sites for endocytosis and subsequent lysosomal degradation. AEP and lamp-2 were colocalized in the late endosomes of the proximal tubule cells (Fig. 4) . In addition, we found that the lysosomes were enlarged in the AEP -/-mice; therefore it is reasonable that AEP would function in the degradation of macromolecules internalized via endocytosis. The lysosomes of AEP -/-mice contained electron-dense and/or membranous materials (Fig. 5D ). These features are analogous to the specific features of lysosomes whose degradation activities are impaired (1). Thus, the AEP deficiency resulted in the development of the lysosomal storage in the kidney In this study, we found that AEP was mainly localized in the late endosomes ( Fig.   4C and D) . Cathepsins B, D, H, and L were found to be mainly localized in the lysosomes, which have been shown to be electron-dense and uniform structures (37) (38) (39) (40) .
Therefore, AEP was located upstream of the cathepsins in the endocytic pathway. We presume that the endocytosed proteins are digested into peptides by AEP within the late endosomes to accelerate the efficiency of their subsequent lysosomal degradation. Indeed, we found the lysosomes of AEP -/-mice became larger with age. We did not detect the large and aberrant lysosomes in 4-month-old AEP -/-mice (data not shown), but we did find them in 7-month-old mice (Fig. 5) . The amounts of cathepsins had already increased in 4-month-old AEP -/-mice (Fig. 3A) . mice were subjected to RT-PCR with a specific primer set for AEP or β-actin. 
